Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in Haematologica

Retrieve available abstracts of 101 articles:
HTML format



Single Articles


    August 2022
  1. INVERNIZZI R
    Images from the Haematologica Atlas of Hematologic Cytology: congenital dyserythropoietic anemia type II.
    Haematologica. 2022;107:1736.
    PubMed    


  2. BENCHEIKH L, Nguyen KA, Chadebech P, Kiger L, et al
    Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell disease.
    Haematologica. 2022;107:1944-1949.
    PubMed    


  3. LEMAIRE B, Abramowski SW
    Alloimmunization against Fy3 is a serious threat in the era of cell therapy.
    Haematologica. 2022;107:1986-1987.
    PubMed    


  4. KNAUS A, Vergez F, Garcia C, Engels H, et al
    Occurrence of a paroxysmal nocturnal hemoglobinuria clone in an essential thrombocythemia: a link between PIGV and MPL.
    Haematologica. 2022;107:1989-1993.
    PubMed    


  5. LOPINTO J, Gendreau S, Berti E, Bartolucci P, et al
    Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis.
    Haematologica. 2022;107:1914-1921.
    PubMed     Abstract available


  6. GUTIERREZ-RODRIGUES F, Beerman I, Groarke EM, Patel BA, et al
    Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis.
    Haematologica. 2022;107:1815-1826.
    PubMed     Abstract available


    July 2022
  7. DE SOUZA LV, Hoffmann A, Fischer C, Petzer V, et al
    Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency.
    Haematologica. 2022 Jul 7. doi: 10.3324/haematol.2022.281149.
    PubMed     Abstract available


  8. INVERNIZZI R
    Images from the Haematologica Atlas of Hematologic Cytology: parvovirus-induced pure red cell aplasia.
    Haematologica. 2022;107:1493.
    PubMed    


  9. DERCHI G, Musallam KM, Pinto VM, Graziadei G, et al
    Tricuspid-valve regurgitant jet velocity as a risk factor for death in beta-thalassemia.
    Haematologica. 2022;107:1714-1718.
    PubMed    


  10. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
    Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results.
    Haematologica. 2022;107:1698-1702.
    PubMed    


  11. ALLARD P, Alhaj N, Lobitz S, Cario H, et al
    Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
    Haematologica. 2022;107:1577-1588.
    PubMed     Abstract available


  12. VERSTOVSEK S, Mesa R, Talpaz M, Kiladjian JJ, et al
    Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia.
    Haematologica. 2022;107:1599-1607.
    PubMed     Abstract available


  13. ABUGA KM, Muriuki JM, Uyoga SM, Mwai K, et al
    Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal Salmonella bacteremia.
    Haematologica. 2022;107:1589-1598.
    PubMed     Abstract available


    June 2022
  14. DONG P, Chen L, Wu H, Huo J, et al
    Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia.
    Haematologica. 2022 Jun 23. doi: 10.3324/haematol.2021.280292.
    PubMed     Abstract available


  15. RODEGHIERO F
    Introduction to a review series on the treatment of thrombocytopenic disorders: something old, something new.
    Haematologica. 2022;107:1239-1242.
    PubMed    


  16. NISHIMURA JI, Ando K, Masuko M, Noji H, et al
    Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2022;107:1483-1488.
    PubMed    


  17. KULOZIK AE
    Does the world need germline editing for beta-thalassemia?
    Haematologica. 2022;107:1235-1236.
    PubMed    


  18. GEISNESS AC, Azul M, Williams D, Szafraniec H, et al
    Ionophore-mediated swelling of erythrocytes as a therapeutic mechanism in sickle cell disease.
    Haematologica. 2022;107:1438-1447.
    PubMed     Abstract available


    May 2022
  19. XU ZL, Xu LP, Wu DP, Wang SQ, et al
    Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study.
    Haematologica. 2022 May 26. doi: 10.3324/haematol.2022.280758.
    PubMed     Abstract available


    April 2022
  20. ROSATO BE, Alper SL, Tomaiuolo G, Russo R, et al
    Hereditary anemia caused by multilocus inheritance of PIEZO1, SLC4A1 and ABCB6 mutations: a diagnostic and therapeutic challenge.
    Haematologica. 2022 Apr 21. doi: 10.3324/haematol.2022.280799.
    PubMed     Abstract available


  21. ALTINTAS B, Giri N, McReynolds LJ, Best A, et al
    Genotype-phenotype and outcome associations in patients with Fanconi anemia: The National Cancer Institute cohort.
    Haematologica. 2022 Apr 14. doi: 10.3324/haematol.2021.279981.
    PubMed     Abstract available


  22. BREGOLAT NF, Ruetten M, Da Silva MC, Aboouf MA, et al
    Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model.
    Haematologica. 2022 Apr 7. doi: 10.3324/haematol.2022.280732.
    PubMed     Abstract available


  23. BENNINGHOVEN-FREY KM, Neuhaus N, Lahtinen AK, Krallmann C, et al
    Early testicular maturation is sensitive to depletion of spermatogonial pool in sickle cell disease.
    Haematologica. 2022;107:975-979.
    PubMed    


    February 2022
  24. AVENOSO D, Marsh JCW, Potter V, Pagliuca A, et al
    SARS-CoV-2 infection in aplastic anemia.
    Haematologica. 2022;107:541-543.
    PubMed    


  25. ABDULMALIK O, Darwish NHE, Muralidharan-Chari V, Taleb MA, et al
    Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia.
    Haematologica. 2022;107:532-540.
    PubMed     Abstract available


  26. PINCEZ T, Fernandes H, Leblanc T, Michel G, et al
    Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden.
    Haematologica. 2022;107:457-466.
    PubMed     Abstract available


  27. CASALE M, Forni GL, Cassinerio E, Pasquali D, et al
    Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.
    Haematologica. 2022;107:467-477.
    PubMed     Abstract available


    January 2022
  28. BREWIN J, El Hoss S, Strouboulis J, Rees D, et al
    A novel index to evaluate ineffective erythropoiesis in hematological diseases offers insights into sickle cell disease.
    Haematologica. 2022;107:338-341.
    PubMed    


  29. TZOUNAKAS VL, Anastasiadi AT, Stefanoni D, Cendali F, et al
    Beta thalassemia minor is a beneficial determinant of red blood cell storage lesion.
    Haematologica. 2022;107:112-125.
    PubMed     Abstract available


    December 2021
  30. ELABBADI A, Voiriot G, Tristan A, Gibelin A, et al
    Lower respiratory tract infection with Staphylococcus aureus in sickle-cell adult patients with severe acute chest syndrome - the STAPHACS Study.
    Haematologica. 2021;106:3236-3239.
    PubMed    


    November 2021
  31. HOOGENBOOM WS, Fleysher R, Soby S, Mirhaji P, et al
    Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - a fifteen hospital observational study in the Bronx, New York.
    Haematologica. 2021;106:3014-3016.
    PubMed    


    October 2021
  32. BROUSSE V, Holvoet L, Pescarmona R, Viel S, et al
    Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?
    Haematologica. 2021;106:2746-2748.
    PubMed    


  33. VANDORPE DH, Shmukler BE, Ilboudo Y, Bhasin S, et al
    A Grammastola spatulata mechanotoxin-4 (GsMTx4)-sensitive cation channel mediates increased cation permeability in human hereditary spherocytosis of multiple genetic etiologies.
    Haematologica. 2021;106:2759-2762.
    PubMed    


  34. EL HOSS S, Cochet S, Godard A, Yan H, et al
    Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease.
    Haematologica. 2021;106:2707-2719.
    PubMed     Abstract available


    September 2021
  35. MUSALLAM KM, Vitrano A, Meloni A, Pollina SA, et al
    Survival and causes of death in 2,033 patients with non-transfusion-dependent beta-thalassemia
    Haematologica. 2021;106:2489-2492.
    PubMed    


  36. MIWATA S, Narita A, Okuno Y, Suzuki K, et al
    Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes.
    Haematologica. 2021;106:2511-2515.
    PubMed    


  37. LIZARRALDE-IRAGORRI MA, Lefevre SD, Cochet S, El Hoss S, et al
    Oxidative stress activates red cell adhesion to laminin in sickle cell disease.
    Haematologica. 2021;106:2478-2488.
    PubMed     Abstract available


  38. VENUGOPAL J, Wang J, Mawri J, Guo C, et al
    Interleukin-1 receptor inhibition reduces stroke size in a murine model of sickle cell disease.
    Haematologica. 2021;106:2469-2477.
    PubMed     Abstract available


  39. KOUNTOURIS P, Michailidou K, Christou S, Hadjigavriel M, et al
    Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.
    Haematologica. 2021;106:2458-2468.
    PubMed     Abstract available


    August 2021
  40. COLIN E, Courtois G, Brouzes C, Pulman J, et al
    Biallelic mutations in the SARS2 gene presenting as congenital sideroblastic anemia.
    Haematologica. 2021 Aug 19. doi: 10.3324/haematol.2021.279138.
    PubMed     Abstract available


  41. BOATENG LA, Schonewille H, Ligthart PC, Javadi A, et al
    One third of alloantibodies in patients with sickle cell disease transfused with African blood are missed by the standard red blood cell test panel.
    Haematologica. 2021;106:2274-2276.
    PubMed    


    July 2021
  42. WANG C, McGraw KL, McLemore AF, Komrokji R, et al
    Dual pyroptotic biomarkers predict erythroid response in lower risk non-del(5q) myelodysplastic syndromes treated with lenalidomide and recombinant erythropoietin.
    Haematologica. 2021 Jul 29. doi: 10.3324/haematol.2021.278855.
    PubMed     Abstract available


  43. BEHRENS YL, Gohring G, Bawadi R, Coktu S, et al
    A novel classification of hematologic conditions in patients with Fanconi anemia.
    Haematologica. 2021 Jul 1. doi: 10.3324/haematol.2021.279332.
    PubMed     Abstract available


  44. LINDER GE, Chou ST
    Red cell transfusion and alloimmunization in sickle cell disease.
    Haematologica. 2021;106:1805-1815.
    PubMed     Abstract available


  45. KAUR K, Huang Y, Raman SV, Kraut E, et al
    Myocardial injury and coronary microvascular disease in sickle cell disease.
    Haematologica. 2021;106:2018-2021.
    PubMed    


  46. GILMARTIN AG, Groy A, Gore ER, Atkins C, et al
    In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor.
    Haematologica. 2021;106:1979-1987.
    PubMed     Abstract available


    June 2021
  47. BREWIN JN, Rooks H, Gardner K, Senior H, et al
    Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC).
    Haematologica. 2021;106:1770-1773.
    PubMed     Abstract available


  48. LAVINYA AA, Razali RA, Razak MA, Mohamed R, et al
    Homozygous Southeast Asian Ovalocytosis in five live-born neonates.
    Haematologica. 2021;106:1758-1761.
    PubMed     Abstract available


  49. MIKKELSEN SU, Safavi S, Dimopoulos K, O'Rourke CJ, et al
    Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance.
    Haematologica. 2021;106:1762-1766.
    PubMed     Abstract available


  50. SRISUWANANUKORN A, Han J, Raslan R, Gowhari M, et al
    Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease.
    Haematologica. 2021;106:1745-1748.
    PubMed     Abstract available


  51. SINGER ST, Fischer R, Allen I, Lal A, et al
    Pituitary iron and factors predictive of fertility status in transfusion dependent thalassemia.
    Haematologica. 2021;106:1740-1744.
    PubMed     Abstract available


  52. ALLALI S, Taylor M, Brice J, Montalembert M, et al
    Chronic organ injuries in children with sickle cell disease.
    Haematologica. 2021;106:1535-1544.
    PubMed     Abstract available


    May 2021
  53. PELLEGRIN S, Severn CE, Toye AM
    Towards manufactured red blood cells for the treatment of inherited anemia.
    Haematologica. 2021 May 27. doi: 10.3324/haematol.2020.268847.
    PubMed     Abstract available


  54. MESSONNIER LA, Riccetti M, Chatel B, Galacteros F, et al
    How to implement endurance exercise training in sickle cell disease.
    Haematologica. 2021;106:1476-1479.
    PubMed    


    April 2021
  55. ZAIMOKU Y, Patel BA, Shalhoub R, Groarke EM, et al
    Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag.
    Haematologica. 2021 Apr 29. doi: 10.3324/haematol.2021.278413.
    PubMed     Abstract available


  56. BROUSSE V, Pondarre C, Kossorotoff M, Arnaud C, et al
    Brain injury pathophysiology study by a multimodal approach in children with sickle cell anemia with no intra or extra cranial arteriopathy.
    Haematologica. 2021 Apr 22. doi: 10.3324/haematol.2020.278226.
    PubMed     Abstract available


  57. CORRE T, Ponte B, Pivin E, Pruijm M, et al
    Heritability and association with distinct genetic loci of erythropoietin levels in the general population.
    Haematologica. 2021 Apr 8. doi: 10.3324/haematol.2021.278389.
    PubMed     Abstract available


  58. CORRE T, Ponte B, Pivin E, Pruijm M, et al
    Heritability and association with distinct genetic loci of erythropoietin levels in the general population.
    Haematologica. 2021 Apr 8. doi: 10.3324/haematol.2021.278389.
    PubMed     Abstract available


  59. NANOU A, Toumpeki C, Fanis P, Bianchi N, et al
    Sex-specific transcriptional profiles identified in beta-thalassemia patients.
    Haematologica. 2021;106:1207-1211.
    PubMed    


    March 2021
  60. AL-SAMKARI H, Kessler CM, Auerbach M
    Recognition of thrombotic risk of thrombocytosis in iron deficiency
    Haematologica. 2021;106:661-663.
    PubMed    


  61. BAROZZI S, Di Buduo CA, Marconi C, Bozzi V, et al
    Pathogenetic and clinical study of a patient with thrombocytopenia due to the p.E527K gain-of-function variant of SRC.
    Haematologica. 2021;106:918-922.
    PubMed    


  62. BOUSSAID I, Le Goff S, Floquet C, Gautier EF, et al
    Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cells.
    Haematologica. 2021;106:746-758.
    PubMed     Abstract available


  63. JIMENEZ K, Leitner F, Leitner A, Scharbert G, et al
    Iron deficiency-induced thrombocytosis increases thrombotic tendency in rats.
    Haematologica. 2021;106:782-794.
    PubMed     Abstract available


    February 2021
  64. KORPORAAL A, Gillemans N, Heshusius S, Cantu I, et al
    Hemoglobin switching in mice carrying the Klf1(Nan) variant.
    Haematologica. 2021;106:464-473.
    PubMed     Abstract available


    January 2021
  65. LIU Y, Dahl M, Debnath S, Rothe M, et al
    Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector.
    Haematologica. 2021 Jan 14. doi: 10.3324/haematol.2020.269142.
    PubMed     Abstract available


  66. STONE EF, Avecilla ST, Wuest DL, Lomas-Francis C, et al
    Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy.
    Haematologica. 2021;106:310-312.
    PubMed    


  67. BLOMBERY P, Fox L, Ryland GL, Thompson ER, et al
    Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
    Haematologica. 2021;106:64-73.
    PubMed     Abstract available


  68. BRODSKY RA, Peffault de Latour R, Rottinghaus ST, Roth A, et al
    Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2021;106:230-237.
    PubMed     Abstract available


    December 2020
  69. BARCIA G, Pandithan D, Ruzzenente B, Assouline Z, et al
    Biallelic IARS2 mutations presenting as sideroblastic anemia.
    Haematologica. 2020;Online ahead of print:0.
    PubMed     Abstract available


  70. KIETZMANN T
    Hypoxia-inducible erythropoietin expression: details matter.
    Haematologica. 2020;105:2704-2706.
    PubMed    


    November 2020
  71. ATAGA KI, Zhou Q, Derebail VK, Saraf SL, et al
    Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysis.
    Haematologica. 2020;Online ahead of print.
    PubMed     Abstract available


  72. BALDUINI CL
    100-year-old Haematologica images: bothriocephalus and pernicious anemia.
    Haematologica. 2020;105:2497.
    PubMed    


  73. MENAPACE LA, Thein SL
    COVID-19 and sickle cell disease.
    Haematologica. 2020;105:2501-2504.
    PubMed    


    October 2020
  74. TELEN MJ
    Pyridoxamine: another vitamin for sickle cell disease?
    Haematologica. 2020;105:2348-2350.
    PubMed    


    September 2020
  75. PATEL BA, Ghannam J, Groarke EM, Goswami M, et al
    Detectable mutations precede late myeloid neoplasia in aplastic anemia.
    Haematologica. 2020;Online ahead of print.
    PubMed    


  76. TELFER P, De la Fuente J, Sohal M, Brown R, et al
    Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients.
    Haematologica. 2020;Online ahead of print.
    PubMed    


  77. MODEPALLI S, Hattangadi SM
    Novel use for selective inhibitors of nuclear export in beta-thalassemia: block of HSP70 export from the nucleus via exportin Xpo1 improves ineffective erythropoiesis.
    Haematologica. 2020;105:2188-2189.
    PubMed    


    July 2020
  78. ANDOLFO I, Martone S, Ribersani M, Bianchi S, et al
    Apparent recessive inheritance of sideroblastic anemia type 2 due to uniparental isodisomy at the SLC25A38 locus.
    Haematologica. 2020 Jul 23. pii: haematol.2020.258533.
    PubMed    


  79. IMMACOLATA ANDOLFO, Stefania Martone, Michela Ribersani, Simona Bianchi, et al
    Apparent recessive inheritance of sideroblastic anemia type 2 due to uniparental isodisomy at the SLC25A38 locus.
    Haematologica. 2020;105:2883-2886.
    PubMed    


  80. SCHULTZ-ROGERS L, Lach FP, Rickman KA, Ferrer A, et al
    Homozygous missense variant in UBE2T is associated with mild Fanconi anemia phenotype.
    Haematologica. 2020 Jul 9. pii: haematol.2020.259275.
    PubMed    


  81. GIRELLI D, Busti F
    Replacing the suppressed hormone: toward a better treatment for iron overload in beta-thalassemia major?
    Haematologica. 2020;105:1752-1754.
    PubMed    


    June 2020
  82. DREVON L, Maslah N, Soret-Dulphy J, Dosquet C, et al
    Anemia and hemodilution: analysis of a single center cohort based on 2858 Red Cell Mass measurements.
    Haematologica. 2020 Jun 25. pii: haematol.2020.249409.
    PubMed    


  83. SUBARNA CHAKRAVORTY, Giselle Padmore-Payne, Fester Ike, Virginia Tshibangu, et al
    COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.
    Haematologica. 2020;105:2691-2693.
    PubMed    


    May 2020
  84. MIZUMAKI H, Hosomichi K, Hosokawa K, Yoroidaka T, et al
    A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia.
    Haematologica. 2020 May 21. pii: haematol.2020.247809.
    PubMed     Abstract available


  85. YOUNG DJ, Dunbar CE
    Immunosuppression and growth factors for severe aplastic anemia: new data for old questions.
    Haematologica. 2020;105:1170-1171.
    PubMed    


    April 2020
  86. FATTIZZO B, Michel M, Zaninoni A, Giannotta J, et al
    Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study.
    Haematologica. 2020 Apr 30. pii: haematol.2020.250522.
    PubMed    


  87. GIANFERANTE DM, Wlodarski MW, Atsidaftos E, Da Costa L, et al
    Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in RPL35A.
    Haematologica. 2020 Apr 2. pii: haematol.2020.246629.
    PubMed     Abstract available


  88. MORI M, Hira A, Yoshida K, Muramatsu H, et al
    Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients.
    Haematologica. 2020;105:1166-1167.
    PubMed    


    March 2020
  89. NARLA A, Mohandas N
    Staying hydrated is important also for erythroblasts.
    Haematologica. 2020;105:528-529.
    PubMed    


    February 2020
  90. LEBENSBURGER JD, Gossett J, Zahr R, Wang WC, et al
    High bias and low precision for estimated versus measured glomerular filtration rate in pediatric sickle cell anemia.
    Haematologica. 2020 Feb 27. pii: haematol.2019.242156.
    PubMed    


  91. HILBERT S, Voill-Glaninger A, Holler B, Minkov M, et al
    Hemolytic anemia due to the unstable hemoglobin Wien: manifestations and long-term course in the largest pedigree identified to date.
    Haematologica. 2020 Feb 6. pii: haematol.2019.236562.
    PubMed    


    January 2020
  92. NEVES JV, Gomes AC, Costa DM, Barroso C, et al
    A role for hepcidin in the anemia caused by Trypanosoma brucei infection.
    Haematologica. 2020 Jan 9. pii: haematol.2019.227728.
    PubMed     Abstract available


  93. ROBACH P, Gammella E, Recalcati S, Girelli D, et al
    Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.
    Haematologica. 2020 Jan 9. pii: haematol.2019.233874.
    PubMed     Abstract available


    December 2019
  94. ORLANDO IMC, Lafleur VN, Storti F, Spielmann P, et al
    Distal and proximal hypoxia response elements cooperate to regulate organ-specific erythropoietin gene expression.
    Haematologica. 2019 Dec 19. pii: haematol.2019.236406.
    PubMed     Abstract available


    November 2019
  95. GENDRON N, Sicre de Fontbrune F, Guyard A, Fadlallah J, et al
    Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and review of literature.
    Haematologica. 2019 Nov 14. pii: haematol.2019.226134.
    PubMed    


    October 2019
  96. OPOKA RO, Hume HA, Latham TS, Lane A, et al
    Hydroxyurea to lower TCD velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort.
    Haematologica. 2019 Oct 24. pii: haematol.2019.231407.
    PubMed     Abstract available


  97. TICHELLI A, Peffault de Latour R, Passweg J, Knol-Bout C, et al
    Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globuline, cyclosporine, with or without G-CSF: a Severe Aplastic Anemia Working Party Trial from the European Group
    Haematologica. 2019 Oct 3. pii: haematol.2019.222562.
    PubMed     Abstract available


  98. FOX LC, Ritchie DS
    Pediatric aplastic anemia treatment patterns and responses; power in the numbers.
    Haematologica. 2019;104:1909-1912.
    PubMed    


    September 2019
  99. STEINBERG-SHEMER O, Goldberg TA, Yacobovich J, Levin C, et al
    Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population.
    Haematologica. 2019 Sep 26. pii: haematol.2019.222877.
    PubMed     Abstract available


    June 2019
  100. SANGKHAE V, Nemeth E
    To induce or not to induce: the fight over hepcidin regulation.
    Haematologica. 2019;104:1093-1095.
    PubMed    


    May 2019
  101. NEMER WE, Koehl B
    Factor H: a novel modulator in sickle cell disease.
    Haematologica. 2019;104:857-859.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: